Navigation Links
Forsyth scientist receives major grant to support rapid, accurate, affordable test for tuberculosis
Date:12/15/2008

Dr. Antonio Campos-Neto, head of the department of Cytokine Biology at The Forsyth Institute, has received a major grant from the internationally renowned Foundation for Innovative New Diagnostics (FIND) to continue his work to develop a test to diagnose active Tuberculosis (TB), the world's second deadliest infectious disease. Dr. Campos-Neto aims to create a rapid, sensitive, non-invasive and accurate TB diagnostic test, modeled after a pregnancy test, which would identify the TB bacterium's molecules present in a patient's urine.

TB is a leading cause of death worldwide, with 1.7 million deaths and 9 million new active cases annually. TB cases are already at epidemic levels in Africa and are on the rise in developing countries throughout the world, particularly among HIV/AIDS patients. This resurgence combined with the ease of transmission through coughing, sneezing and other common activities, and the emergence of drug resistant TB strains is leading to a growing fear of a global spread of the disease.

Among the main barriers to preventing the spread of TB are the shortcomings of existing diagnostic tests, including: inaccurate diagnoses, limited test sensitivity, invasive sample collection, time-consuming testing and most importantly, failure to distinguish between active and latent cases.

"We are in the preliminary stages of establishing a methodology that allows us to detect minute traces of the TB antigens that are excreted in the urine by a TB-infected patient. What is so exciting about this project is that if we are successful it will contribute tremendously to the control of a disease that kills close to two million people every year," says Dr. Campos-Neto.

The research has already detected molecules produced by TB in the urine of infected mice and humans. Establishing a test that can be used in a clinical setting offers several potential benefits:

  • confirming the diagnosis of active TB, not latent or dormant infection
  • the test does not require expensive equipment and can be performed anywhere in the world, including the most remote locations
  • the test result is easy to read and obtained in less than five minutes, enabling the immediate initiation of treatment
  • urine is a far easier sample to collect and, unlike current sample collection, is completely non-invasive
  • the presence of TB antigens in urine may be detectable earlier than through other samples, leading to earlier treatment and increased survival rates

Philip Stashenko, President and CEO of The Forsyth Institute, says, "Dr. Campos-Neto's research offers a tremendous opportunity to address a critical worldwide public health problem, and extends the Institute's mission to study systemic disease. This would be an important breakthrough in the diagnosis and treatment of TB."

Recent studies show that an improved TB diagnostic test could save as many as 625,000 lives every year. Without a new, more efficient and more reliable diagnostic test, TB will continue to spread at alarming rates.


'/>"/>

Contact: Matt Ellis
matt@ellisstrategies.com
978-887-6561
Forsyth Institute
Source:Eurekalert

Related biology news :

1. Forsyth scientists trigger cancer-like response from embryonic stem cells
2. UK scientists working to help cut ID theft
3. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
4. Comet probes reveal evidence of origin of life, scientists claim
5. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
6. Male elephants get photo IDs from scientists
7. Scientists retrace evolution with first atomic structure of an ancient protein
8. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
9. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
10. Clemson scientists shed light on molecules in living cells
11. Scientists tackle mystery mountain illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology: